Suzanne Ildstad - Insider Trading & Ownership

Entity
Individual
Location
C/O Talaris Therapeutics, Inc., 93 Worcester Street, Suite 120, Wellesley, MA
Summary
The estimated net worth of Suzanne Ildstad is at least $75.2M dollars as of June 14, 2023. Suzanne Ildstad is the Director of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $75.2M.
All Insider Reports
All Insider Reports

Ownership of Suzanne Ildstad

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. Director $75.2M Jun 12, 2023

Insider Transactions Reported by Suzanne Ildstad:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.